HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Risk Assessment

View and export this data going back to . Start your Free Trial

What is HH Biotechnology Holdings Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of HH Biotechnology Holdings Co is: No Data: Cannot be evaluated.

Competitive Comparison of HH Biotechnology Holdings Co's Risk Assessment

For the Real Estate Services subindustry, HH Biotechnology Holdings Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HH Biotechnology Holdings Co's Risk Assessment Distribution in the Real Estate Industry

For the Real Estate industry and Real Estate sector, HH Biotechnology Holdings Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where HH Biotechnology Holdings Co's Risk Assessment falls into.

HH Biotechnology Holdings Co (OTCPK:HHBT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

HH Biotechnology Holdings Co Risk Assessment Related Terms

Thank you for viewing the detailed overview of HH Biotechnology Holdings Co's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » Real Estate » HH Biotechnology Holdings Co (OTCPK:HHBT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 69 Heping North Street, C-Site, 25th - 26th Floor, Presidential Building, Heping District, Shenyang, CHN, 110003

Website

http://www.greatchinaholdings.com

HH Biotechnology Holdings Co is engaged in developing, producing and marketing of healthy food, supplements, medicine, and cosmetics.

Executives

Yizhao Zhang

director

45 OLD MILLSTONE DRIVE, NIT 6, EAST WINDSOR NJ 08520

HH Biotechnology Holdings Co (HH Biotechnology Holdings Co) Headlines

No Headlines